ELV FRAUD ALERT: Elevance Health, Inc. Investors are Reminded of Ongoing Securities Fraud Class Action — Contact BFA Law by July 11 Legal Deadline (NYSE:ELV)

NEW YORK, June 22, 2025 (GLOBE NEWSWIRE) — Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE: ELV) and certain of the Company's senior executives for potential violations of the federal securities laws.
If you invested in Elevance you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elevance-health-inc.
Investors have until July 11, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased Elevance common stock. The case is pending in the U.S. District Court for the Southern District of Indiana and is captioned Miller v. Elevance Health, Inc., et al. , No. 25-cv-0092.
Why was Elevance Sued for Securities Fraud?
Elevance provides health insurance plans. This includes contracting with states to administer Medicaid benefits. States routinely review Medicaid eligibility, but during COVID, the federal government paused this process. The pause ended in 2023, and states resumed redetermining Medicaid eligibility.
During the relevant period, Elevance represented that it was closely monitoring the cost trends associated with the redetermination process and that the rates Elevance was negotiating were sufficient to address the risk profiles of those patients staying on Medicaid.
As alleged, in truth, the redeterminations caused a significant increase in the acuity and utilization of Elevance's Medicaid members. What's more, the shift occurred to a degree that was not reflected in Elevance's rate negotiations or in its financial guidance for 2024.
The Stock Declines as the Truth is Revealed
On July 17, 2024, Elevance stated that it was now 'expecting second-half utilization to increase in Medicaid' and that it was 'seeing signs of increased utilization across the broader Medicaid population.' On this news, the price of Elevance stock declined $32.21 per share, or nearly 6%, from $553.14 per share on July 16, 2024, to $520.93 per share on July 17, 2024.
Then, on October 17, 2024, Elevance announced its Q3 2024 financial results, revealing that its missed consensus earnings per share ('EPS') expectations by $1.33, or 13.7%, 'due to elevated medical costs in [its] Medicaid business.' On this news, the price of Elevance stock declined $52.61 per share, or nearly 11%, from $496.96 per share on October 16, 2024, to $444.35 per share on October 17, 2024.
Click here if you suffered losses: https://www.bfalaw.com/cases-investigations/elevance-health-inc.
What Can You Do?
If you invested in Elevance you may have legal options and are encouraged to submit your information to the firm.
All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.
Submit your information by visiting:
https://www.bfalaw.com/cases-investigations/elevance-health-inc
Or contact:Ross Shikowitz
[email protected]
212-789-3619

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Wall Street Journal

16 minutes ago

• Wall Street Journal

Trump's ‘Big, Beautiful' Bill Gets Slimmed Down in Senate

WASHINGTON—President Trump's 'big, beautiful' bill is getting smaller just as Republicans head into a crucial week, after the Senate's rules arbiter decided several controversial provisions don't qualify for the special procedure the GOP is using to bypass Democratic opposition. The tax-and-spending megabill centers on extending Trump's 2017 tax cuts, delivering on the spirit of his campaign promises to eliminate taxes on tips and overtime, and providing big lump sums of money for border security and defense. Those new costs are partially offset by spending cuts, in particular to Medicaid.

Business Insider

an hour ago

• Business Insider

‘Still Not a Bargain,' Says Top Investor About Nike Stock

'Just Do It,' goes the motto that Nike (NYSE:NKE) made a household catchphrase. With its branded 'Swoosh' and world-famous spokespeople, it is no stretch to argue that Nike helped to build the premium shoe market — one that grew by leaps and bounds earlier this decade. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Indeed, the COVID years saw a major spike in Nike's footwear sales – from $23.3 billion in 2020 to over $35 billion in 2023 – though growth has been slowing of late. Last year saw footwear revenues decrease slightly, and its share price has fallen almost 40% during the past twelve months. This week, Nike will be releasing its FQ4 2025 results, and consensus estimates are not exactly bullish. Analysts are expecting total revenues of $10.7 billion – down 15% year-over-year – while a projected EPS of $0.12 would represent an 89% decrease year-over-year. One top investor known by the pseudonym Stone Fox Capital thinks that the growing competition will continue to present stiff resistance going forward. 'Nike remains overvalued despite a significant price decline, with the market underestimating downside risks and ongoing competitive pressures,' explains the 5-star investor, who is among the top 3% of TipRanks' stock pros. The biggest challenge for Nike going forward will be the growing competition, asserts Stone Fox Capital, citing On Holding and HOKA as two of the biggest threats. For instance, ONON's On Running is expected to grow revenues by 40% this year. Still, NKE is trading 'at multiples above the market,' despite forecasts of stagnating growth going forward. Stone Fox Capital spots quite a disconnect – one that the market has yet to take fully into account. 'Nike should be viewed based on the readily available data of a massive athletic footwear company that hasn't grown in years facing immense competition,' adds Stone Fox Capital. Stone Fox Capital is urging investors to pay attention to upcoming guidance for the next quarter, which the investor predicts will be a 'horrible' forecast. Needless to say, Stone Fox Capital does not believe that 'Just Do It' is good advice for would-be investors at present. 'The stock might be down substantially from the all-time highs a few years ago, but Nike isn't actually trading like the business is under pressure,' concludes Stone Fox Capital, who rates NKE a Sell. (To watch Stone Fox Capital's track record, click here) Wall Street is overall positive when it comes to Nike, though not overwhelmingly. With 12 Buy and 11 Hold ratings, NKE is a consensus Moderate Buy. Its 12-month average price target of $71.24 has an upside of ~19%. (See NKE stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights.

New York Post

3 hours ago

• New York Post

Life Time athletic club opening at 452 Fifth Ave.

The owners of 425 Fifth Avenue, aka 10 Bryant Park between East 39th and 40th streets, landed another big catch at their tower where Amazon recently signed for 330,000 square feet — and it all started with a game of pickleball. In one of Manhattan's largest retail-space deals this year, burgeoning 'athletic urban country club' Life Time signed for 52,000 square feet on four levels, including in the soon to be vacated, 17,000 square-foot Staples store. It will open in early 2027 behind a prominent Fifth Avenue entrance. The Life Time deal all but completes the leasing picture at the 865,000 address, which consists of three formerly separate structures that include the 10-story Knox Building. Advertisement 4 425 Fifth Avenue, aka 10 Bryant Park between East 39th and 40th streets, center. Google Maps Life Time has 180 clubs in the US and Canada. Chief property development officer Parham Javaheri said 10 Bryant Park checked all the boxes for what he wanted in Midtown. 'We want to serve both our residential and commercial cores,' he said. 'Although the location is obviously more commercial, there's a lot of residential growth nearby as well.' Advertisement Life Time, founded by chairman and CEO Bahram Akradi, has seven other Manhattan locations, two in Brooklyn, and another coming at the supertall Brooklyn Tower condo project. Javaheri said, 'We want to grow methodically. Meaning, we want destinations that let us stay true to what Life Time is, and they require a lot of space.' In fact, several others in the city are even larger than at 10 Bryant Park with 80,000 square feet each. The 10 Bryant Park edition will boast a luxurious, co-ed 'wet' suite with steam rooms, saunas, hot tubs and cold plunges; a workout floor with best-in-class cardio and resistance-training equipment; a recovery space with massage chairs and body-compression technology; and a half-dozen boutique-style studios for group fitness formats. 4 A rendering of the Life Time athletic club location at 10 Bryant Park, which is expected to open in early 2027. LIFE TIME Advertisement Eli Elefant, CEO of 10 Bryant Park landlord Property & Building Corp., said, 'We had the privilege or repositioning the building in a post-Covid world. It gave us the ability to reimagine what a commercial building can look like in a challenging environment.' Elefant said, 'When we lost our big bank tenant, HSBC, we got all their antiquated space back. Our thought was to lean heavily into the tech sphere and market the former bank space to big users and we were ultimately successful.' With the Amazon deal, the 30-story tower's office floors are 100% leased. What he called a 'blank slate' after HSBC decided to move to The Spiral in Hudson Yards also suggested the need to deliver what Amazon and many other 21st Century tenants want: a spectacular 'wellness' amenity. 'We didn't just want to build a gym,' Elefant chuckled. 4 Eli Elefant, center, the CEO of 10 Bryant Park owner Property & Building Corp., and Life Time chief property development officer Parham Javaheri, right, bonded over their vision during a pickleball game. LIFE TIME Advertisement Introduced by brokers, he and Javaheri first met on Oct. 17, 2023. 'We talked about a lifestyle-physical concept,' Elefant said. 'I said, 'Why don't we meet for a workout?'' Javaheri recalled, 'We played pickleball at 1 Penn and at Sky on West 42nd Street. Eli told us what his vision was for a strong amenity. We formed a good friendship.' 4 A rendering of the interior of the announced Life Time athletic club at 10 Bryant Park. LIFE TIME The competition 'was a great way for him to humiliate me,' Elefant laughed. 'But I'm a firm believed in personal synergies' in a changed real estate market that needs to be 'less sharp-elbows than collaborative, although I'm not sure everyone got the message.' Atlantic Retail's Joe Mastromonaco represented Life Time and JLL's Patrick Smith acted for the ownership. Property & Building's parent company owns 14 million square feet of buildings in Israel, but 10 Bryant Park is the only one in New York it wholly owns although it has discreet investments at others.